Posted in | News

Gold River Productions’ PV Solar Roof for SIP’s Market

John Ohlin, President and Chief Executive Officer of Gold River Productions Inc. (PINKSHEETS: GRPS) reported today that the Company's Patent Pending technology of a monolithic, photo-voltaic solar roof has been embraced by the SIP's industry.

"SIP stands for structural insulated panel which is an emerging construction technology particularly in commercial construction," Mr. Ohlin reported. "An Executive at SIP school and the SIP Association has been in extensive discussions with our Chief Technology Officer on how our patent pending P.V. photo-voltaic roof will enhance the advancement of building projects within this market segment," Mr. Ohlin also reported.

"The potential market for our patent pending monolithic, P.V. solar roof is huge. In the U.S. alone in 2010, $2.4 trillion dollars of commercial and civil construction (the major market for our technology) is in the "post bid" phase Mr. Ohlin reported. "The roof portion of these projects is between 5% - 10% of the total cost which means that the total available market for our P.V. solar roof equals between $120 billion to $240 billion in the U.S. alone," he said.

"Our technology will allow solar roofs to be installed in 60' free span lengths, with an R value in excess of R-42. Photo-voltaic solar cells, producing up to 13 watts of power per hour per square foot are integrated into the exterior skin of the monolithic, structural insulated roof panels," he stated. "At full production, our machinery will be able to produce in excess of one million square feet of P.V. solar roof panels per month; generating potential sales for AeroQuest in excess of thirty million dollars per month."

Source: http://www.atpanels.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.